Expert's Opinion
-
Capsules | Cold Chain Management | Injectables | Serialization | Solid Dosage/Semi-solids | Supply Chain
Pharmaceutical Packaging Trends
Opportunities across next-gen products, transforming how chronic diseases are treated, and favorable government regulations are driving today's market.Thomas N. Podesta, Global Vice President, Sales, West Contract Manufacturing 06.02.20
-
Facilities | Information Technology
Prepare Your Facility for a Pandemic – How Data Can Help
Data is being used to monitor and reduce the impact of the virus, and to allocate resources and anticipate needs.David Keith, Director of Strategic Facility Planning, CRB 05.29.20
-
Biologics, Proteins, Vaccines | Clinical Trials | Drug Development | Logistics
The Importance of CAR-T Cell Therapy in Clinical Trials
The Industry’s Evolving, Maturing FocusPanteli Theocharous, Global Vice President, Cell and Gene Therapy Strategy Lead, PPD 05.26.20
-
cGMP Manufacture | Clinical Trials | Drug Development | Information Technology | R&D
COVID-19’s Long-Term Impact on Drug Development: The New Pragmatism
The rise of new tools and approaches, an increase in regulatory responsibility, and the need for speed.Paul Bridges SVP Worldwide Head Regulatory & Access, Parexel and Sheela Hegde, Partner and Managing Director, Health Advances 05.18.20
-
Supply Chain
Maximizing Potential
Creatively navigating the clinical supply chain challenges during COVID-19Sharon Courtney, Logistics Services Manager, Almac 05.04.20
-
cGMP Manufacture | Drug Development
Accelerating Life-Saving Drugs to Market During COVID-19 Pandemic
Streamlining drug development with CDMOsMasha Kononov, Senior Director Emerging Pharma, USA, Arcinova, and Stephen Brown, Pharmaceutical and Biotech Consultant 05.01.20
-
Drug Discovery | Information Technology
Overcoming Three Common eDiscovery Challenges
When you know where your data is, that it is secure and that there are solid processes in place to handle it, you are in control.Barry A. Schwartz, SVP, Advisory Services at BIA 04.29.20
-
cGMP Manufacture | GMPs/GCPs | Inspections | Regulatory Affairs
FDA cGMP Inspections Amid COVID-19 Pandemic
Despite FDA's postponement of most facility inspections, the pharma manufacturing industry should be prepared for heightened scrutiny as this crisis develops.John J. Carney, Lee H. Rosebush, Susrut A. Carpenter, Andrew M. Serrao, BakerHostetler 04.22.20
-
Drug Development | GMPs/GCPs | Regulatory Affairs
FDA’s Emergency Use Authorizations
Aggressive Action Taken to Combat COVID-19Chad Landmon and Drew Hillier, Axinn, Veltrop & Harkrider LLP 04.20.20
-
Clinical Trials | Drug Development
How to Design Trials to be More Patient-Centered
Three lessons learned and how pharma can use validated measures and strategies to engage patients at every stage in the drug development lifecycle.Jean Paty, Vice President, Patient Centered Sciences, IQVIA, Matthew Reaney, Senior Principal, Patient Centered Sciences, IQVIA 04.16.20
-
Biologics, Proteins, Vaccines | Drug Development | Information Technology
Speeding Vaccine Development with Advanced Analytics
Having immediate access to wide ranging resources of data can help speed the COVID-19 vaccine development processDr. Shlomi Madar, VP of Healthcare Solutions, Signals Analytics 04.15.20
-
Clinical Trials
COVID-19: Keeping Clinical Trials Moving
How DTP and virtual services keep clinical trials moving during pandemic and beyondAriette van Strien, President, Marken 04.06.20
-
Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development | Scale-up/Technology Transfer
Robust Response to COVID-19 Demand
What it’s going to take to develop, scale-up, and manufacture the products needed to address the COVID-19 outbreak.Christa Myers, Pharmaceutical Market Sector Lead, CRB 03.31.20
-
Supply Chain
Best Practices for Supply Chain Disruption
Top 3 “Best Practice” methods for planning your product label orders during supply chain disruptionRob Freeman, Director of Business Development and Marketing, Label Solutions Inc. 03.27.20
-
Drug Discovery | R&D
The Future of Pharma Beyond Blockbusters
Advancements in genomics and technology are improving our ability to develop precise drugs and targeted therapiesBarrie Dowsett, Chief Executive Officer, Myriad Associates 03.20.20
-
Clinical Trials | Information Technology
Ensuring Clinical Trial Progress During COVID-19
Through action and technology, we can expand and accelerate critical medical research in the race to find a vaccine for COVID-19Alison Holland, Head of Virtual Clinical Trials, Medable 03.18.20
-
cGMP Manufacture
Elevating Process Engineering to Improve Predictability, Reliability & Productivity
It is past time for drug makers to shift from a document- and compliance-centered paradigm to one focused on science and engineeringCathal Strain, President, Neo PLM 03.18.20
-
Clinical Trials | Information Technology
Risk-Based Monitoring of Clinical Trials
Central risk-based monitoring supports reduced cost and higher levels of data qualitySheelagh Aird, Head, Clinical Data Operations, PHASTAR 03.13.20
-
Cold Chain Management
2020 Cold Chain Forecast
Ushering in the next decade of changeKevin Lawler, Vice President of Sales, Pelican BioThermal 03.06.20
-
Supply Chain
Trends Affecting the Generic Drugs Sector in 2020
Supply chain issues, the need for additional talented chemists, lower drug prices, growth of development in the U.S. will be key factorsEd Price, President, Seqens NA 02.21.20
